Alnylam, a leader in RNA interference (RNAi) therapeutics, will utilize the AGD dataset to inform development of 'gene ...

Alnylam, a leader in RNA interference (RNAi) therapeutics, will utilize the AGD dataset to inform development of 'gene silencing' medicinesMembers leverage AI-powered dataset to accelerate ...

Detailed price information for Arrowhead Pharma (ARWR-Q) from The Globe and Mail including charting and trades.

Detailed price information for Arrowhead Pharma (ARWR-Q) from The Globe and Mail including charting and trades.

This topic explores the application of advanced biotechnological approaches—including genetic engineering tools such as ...

Ionis Pharmaceuticals' shares surged 42% this past week after the developer of RNA-targeted therapies came out with positive data from two pivotal Phase III trials assessing a potential new indication ...

Arrowhead Pharmaceuticals (NASDAQ:ARWR) sued Ionis Pharmaceuticals (NASDAQ:IONS) in a Delaware District Court on Wednesday as ...

Rising prevalence of genetic disorders, supportive regulatory frameworks, and advancements in gene and RNA-based therapies are fueling market expansion.

Oligonucleotides are short strands of DNA or RNA that scientists use to influence biological processes at the genetic level.

Humanin is a mitochondria‑derived micropeptide encoded within the mitochondrial 16S rRNA gene. This small peptide, ...

In quantum mechanics, particles such as electrons act like waves and can even interfere with themselves—a striking and ...

Researchers at Tel Aviv University have developed a new approach for using locked nucleic acids (LNAs)—a particularly stable ...